Pancreatic cancer drug daraxonrasib: Daraxonrasib has emerged as a promising treatment for advanced pancreatic cancer, showing remarkable results in recent trials. Among 61 patients tested, an impressive 90.2%…
Pancreatic cancer drug daraxonrasib: Daraxonrasib has emerged as a promising treatment for advanced pancreatic cancer, showing remarkable results in recent trials. Among 61 patients tested, an impressive 90.2% had their tumor growth stopped, while 60.7% experienced shrinkage or complete disappearance of tumors. The outcome included five patients with no detectable tumors, marking a transformative step in cancer therapy.
This is a source-linked briefing. Read the original report from The Economic Times .